3137 results for «846»

Filter By

3137 results

Revolutionising coronary calcium treatment: unleashing the potential of intravascular lithotripsy

21 Sep 2023 – From AICT-AsiaPCR 2023

Over the last five years, we have learned that there is a new tool for treating calcium, the greatest enemy of interventional cardiology, which can take various forms: intravascular lithotripsy. In this session, look at how to master this technique in different scenarios, from eccentric calcified...

Revolutionising coronary

Clinical cases - Structural interventions - Session 6

07 Oct 2022 – From AICT-AsiaPCR 2022

A hybrid approach in complex PCI: can DES and DCB be complementary?

21 Sep 2023 – From AICT-AsiaPCR 2023

Watch this case-based session to follow discussion about how to choose between DES & DCB,  how both can be complementary in diffuse disease as well as in complex PCI, and how physiology and imaging can help guiding PCI, and follow a patient's treatment live.

A hybrid approach in

Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?

22 Sep 2023 – From AICT-AsiaPCR 2023

This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...

Leave nothing behind DCB-only PCI strategy evidence changed today practice

The importance of SEE-PREP-TREAT in left main bifurcation

22 Sep 2023 – From AICT-AsiaPCR 2023

This session is recommended for you if you are seeking insights into the advantages of using IVUS imaging over visual assessment for better outcomes in left main bifurcation procedures. Discuss with experts the benefits of using RotaCUT in lesion preparation for left main bifurcation and explore...

The importance of SEE-PREP-TREAT

Clinical cases - Coronary interventions - Session 5

07 Oct 2022 – From AICT-AsiaPCR 2022

Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV

22 Sep 2023 – From AICT-AsiaPCR 2023

This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.

Essentials of lifetime

TAVI step by step

19 Nov 2023 – From PCR London Valves 2023

Watch this interactive session to get tips and tricks to solve the technical difficulties that can come up during a TAVI, and learn more about mastering CT imaging for successful TAVI planning, understanding valve selection principles, and refining TAVI procedures for improved efficiency and technique.

TAVI step by step

Challenging TAVI cases

19 Nov 2023 – From PCR London Valves 2023

This PCR London Valves 2023 session aims to analyse some of the complex aspects of TAVI by looking at challenging clinical and anatomical scenarios to enable you to learn how to manage potential complications by learning about innovative strategies and exploring different approaches.

Challenging TAVI cases

Planning and execution of re-do TAVI (TAV-in-TAV) procedures

19 Nov 2023 – From PCR London Valves 2023

Redo TAVI poses challenges but can be managed with a step-by-step procedural plan, ensuring better acute and long-term outcomes. Guidelines and industry resources aid in planning, yet forthcoming registry studies are essential for further data and insights. Watch this session to find out more!

Planning and execution of re-do TAVI (TAV-in-TAV) procedures

How to treat my patient with primary mitral regurgitation?

20 Nov 2023 – From PCR London Valves 2023

In this session, study the different cases of primary mitral regurgitation in detail, with diagrams, videos and even recommendations, to find out when to opt for replacement rather than repair, how to better manage transcatheter mitral replacement, and how to get to grips with endoscopic mitral...

How to treat my patient with primary mitral regurgitation?

How to treat my patient with combined aortic and mitral valve disease

20 Nov 2023 – From PCR London Valves 2023

Explore this session to gain insights into diverse treatment options for combined heart valve disease. Examine the distinctions between surgical and transcatheter approaches, understanding their nuances, the sequential order of treatment and technical considerations crucial for transcatheter interventions.

How to treat my patient with combined aortic and mitral valve disease

20 years of TEER: a journey at the crossroads of the human heart

20 Nov 2023 – From PCR London Valves 2023

In 2023, with 200,000 MitraClips performed, the session concluded by posing the question of how many M-TEERs would be conducted by 2026. While the answer remains a mystery until PCR LV 2026, explore the fascinating history of transcatheter edge-to-edge mitral valve repair in this session. Delve...

20 years of TEER: a journey at the crossroads of the human heart

Transcatheter tricuspid edge-to-edge repair step-by-step

21 Nov 2023 – From PCR London Valves 2023

In this interactive session, the comprehensive case of an 81-year-old patient with atrial fibrillation, coronary artery disease and chronic kidney disease, presenting with fatigue, shortness of breath and peripheral oedema, is dissected, allowing meticulous analysis of each step of transcatheter edge-to-edge tricuspid valve repair. Don't miss...

Transcatheter tricuspid edge-to-edge repair step-by-step

How to treat my patient with combined mitral and tricuspid valve disease

21 Nov 2023 – From PCR London Valves 2023

Follow the discussion around the case of this 77-year-old patient with hypertension, diabetes, dyslipidemia, already on dialysis twice a week for chronic kidney disease, and with an implantable automatic defibrillator, who presents with permanent atrial fibrillation, and severe secondary mitral and tricuspid regurgitation, and learn more...

How to treat my patient with combined mitral and tricuspid valve disease

Welcome to GulfPCR Valves 2023

05 Dec 2023 – From GulfPCR-GIM 2023

Find out more about this very first edition of GulfPCR Valves by discovering its Course directors, its objectives, its programme, its partners and its interactivity. If you are a heart valve interventionist or an imager, and you have a keen interest in valve disease, and TAVI in...

Welcome to GulfPCR Valves 2023

TAVI for bicuspid aortic stenosis patients - Recorded cases

05 Dec 2023 – From GulfPCR-GIM 2023

Discover two clinical cases of optimising TAVI procedure in bicuspid aortic valve patients, taking into account the current sizing options in such anatomy.

  • An 84-year-old woman with a history of LAD PCI in 2020, presented a symptomatic severe aortic stenosis and grade 3 regurgitation with a preserved LV...
TAVI for bicuspid aortic stenosis patients - LIVE case

TAVI and access: alternating is wise

16 Jan 2024 – From GulfPCR-GIM 2023

Given that 10-20% of patients have restricted or even impossible femoral access, it is important, for both procedural and patient safety, that alternative access is sometimes considered. Learn what options are available, whether surgical or transcatheter, depending on the patient, and how to put these choices into...

TAVI and access: alternating is wise

Newer generation self-expanding platform: technical optimisation for common clinical challenges

05 Dec 2023 – From GulfPCR-GIM 2023

The primary focus of this GulfPCR-GIM 2023 session revolves around pre-procedural planning considerations, valve selection, and managing complex anatomies using both traditional self-expanding valves and the Evolut FX system. Additionally, the session aims to explore the work-up protocol for patients grappling with severe AS and advanced...

Newer generation self-expanding platform: technical optimisation for common clinical challenges

Evidence gap and new indications

05 Dec 2023 – From GulfPCR-GIM 2023

Follow discussions about a 74-year-old patient with NYHA III.IV dyspnea, DM, HTN, paroxismal AF and LVEF 20% to find out more about symptomatic moderate aortic stenosis, and about an 84-year-old patient with dyspnea NYHA III, HTN, no significant CAD, and follow-up for moderate aortic regurgitation, and...

Evidence gap and new indications
Didn’t find what you were looking for?